Similar articles

• Impact of the COVID-19 pandemic on polio care: a warning.

  Murtaza G, Bashir S, Khanum J, Sultana R. Murtaza G, et al. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1167-1168. doi: 10.26355/eurrev_202102_24817. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629285 No abstract available.
• Polio is back? The risk of poliomyelitis recurrence globally, and the legacy of the severe acute respiratory syndrome coronavirus 2 pandemic.

  Castilletti C, Capobianchi MR. Castilletti C, et al. Clin Microbiol Infect. 2023 Apr;29(4):414-416. doi: 10.1016/j.cmi.2022.12.005. Epub 2022 Dec 8. Clin Microbiol Infect. 2023. PMID: 36503117 Free PMC article. No abstract available.
• COVID-19 from a polio perspective.

  Hill R. Hill R. Vaccine. 2021 Dec 3;39(49):7117-7118. doi: 10.1016/j.vaccine.2021.10.061. Vaccine. 2021. PMID: 34862004 No abstract available.
• Impact of COVID-19 on polio vaccination in Pakistan: a concise overview.

  Din M, Ali H, Khan M, Waris A, Ullah S, Kashif M, Rahman S, Ali M. Din M, et al. Rev Med Virol. 2021 Jul;31(4):e2190. doi: 10.1002/rmv.2190. Epub 2020 Nov 11. Rev Med Virol. 2021. PMID: 33176028 Review.
• Hypothetical emergence of poliovirus in 2020: part 1. Consequences of policy decisions to respond using nonpharmaceutical interventions.

  Thompson KM, Kalkowska DA, Badizadegan K. Thompson KM, et al. Expert Rev Vaccines. 2021 Apr;20(4):465-481. doi: 10.1080/14760584.2021.1891888. Epub 2021 May 5. Expert Rev Vaccines. 2021. PMID: 33624568 Review.